Immune function/DNA repair assay that measures total serum thiols data

OXGN (New York) released preliminary results of a comparison of its immune function/DNA repair assay with beta-2 microglobulin, a commonly used assay, in 133 HIV-positive patients.

The company's test had a predictive relation to survival that was statistically significant at the p<0.001 level in two statistical analyses. The other test was significantly predictive of survival in one analysis at the p<0.05 level. ...